AUG 13, 2019 8:02 AM PDT

Novel Drug Target for Dilating Microvessels

WRITTEN BY: Nouran Amin

Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood vessels that more blood is needed. Their studies were particularly helpful in diastolic heart failure which is a characterized by the inability of the left ventricle to relax and fill blood adequately. the natural inhibitor of that chemical goes up and communication with upstream blood vessels goes down. And, when they bring the inhibitor down, it reduces the heart dysfunction, they report in the journal Circulation: Heart Failure.

Learn more on how our hearts pump blood:

"What we are talking about here even many cardiologists cannot see," says Dr. Zsolt Bagi from Augusta University’s Department of Physiology who was refereeing to the microvasculature of the heart muscle.

Although when we think of heart failure—thoughts of high cholesterol, high blood pressure, and smoking start to surface. However, heart failure can also arise from microvascular dysfunction.

In the study, published in the journal Circulation: Heart Failure, researchers found that the chemical adenosine—known to facilitate dilation—will not function effectively if levels if its inhibitory compound, adenosine kinase, are increased.

“In a healthy state, the two provide balance for each other, but adenosine levels are typically somewhat higher. If you are healthy, when a portion of your heart needs more blood and oxygen for that walk or to hike up some stairs, adenosine levels go up and adenosine kinase levels decrease, which is good,” says MD/PhD student Alec Davila.

“Now they've shown that in their animal model of disease, giving a drug that blocks adenosine kinase boosts the intrinsic adenosine production back where we need it, which is also good,” says Bagi.

Researchers have found that adding the adenosine kinase inhibitor has improved the dilation of blood vessels in both animal and human microvessels.

"The novelty here is that adenosine really amplifies the signal," says Bagi. “The adenosine kinase inhibitor they used appears to be pretty specific, and is being looked at as well for epilepsy, where levels of adenosine kinase also are high.”

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 11, 2019
Drug Discovery & Development
DEC 11, 2019
Drug Candidates for Alzheimer Disease May Reverse Effects of Aging
Researchers using mouse models of Alzheimer disease were able to demonstrate that the investigational drug candidates ‘CMS121’ and ‘J147&...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-resistant bacteria known to man. ...
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Diabetic Drug Increasces Risk of Heart Complications
A drug by the name of ‘rosiglitazone’ used to treat type 2 diabetes was found to be associated with increased risk of heart problems, especiall...
Loading Comments...